Trials / Terminated
TerminatedNCT00997828
Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST)
Randomized Comparison of Coronary Artery Bypass Surgery and Everolimus-Eluting Stent Implantation in the Treatment of Patients With Multivessel Coronary Artery Disease (BEST)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 888 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether the safety and efficacy of coronary stent implantation using Everolimus-Eluting Coronary Stent System (Abbott, Boston Scientific) is not inferior to coronary artery bypass grafting (CABG) for the treatment of patient with multivessel coronary artery disease (CAD).
Detailed description
The primary purpose of the BEST Study is to determine whether the safety and efficacy of coronary stent implantation using everolimus-eluting balloon expandable stents is not inferior to coronary artery bypass grafting for the treatment of multivessel coronary artery disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | everolimus-eluting stent | Xience V stent |
| PROCEDURE | coronary artery bypass graft surgery | coronary artery bypass graft surgery |
Timeline
- Start date
- 2008-07-28
- Primary completion
- 2016-04-01
- Completion
- 2019-04-05
- First posted
- 2009-10-19
- Last updated
- 2019-05-10
Locations
27 sites across 4 countries: China, Malaysia, South Korea, Thailand
Source: ClinicalTrials.gov record NCT00997828. Inclusion in this directory is not an endorsement.